There was a decreasing trend in RUNX1 transcriptional levels from stage one to stage four in breast cancer patients ( Figure 3B ).
← all excerpts
Comprehensive Analysis of RUNX and TGF-β Mediated Regulation of Immune Cell Infiltration in Breast Cancer.
1
—
—